Exhibit 99.67

		5251 Duke St., Suite 400	Tel:	902-424-7059
	Securities	Duke Tower	Fax:	902-424-4625
	Commission	P.O. Box 458	Website: nssc.novascotia.ca
		Halifax, Nova Scotia
		B3J 2P8

RECEIPT

Immunovaccine Inc.

This is the receipt of the Nova Scotia Securities Commission for the Preliminary Short Form Prospectus of the above Issuer dated January 30, 2018 (the Preliminary Prospectus).

This receipt also evidences that the Ontario Securities Commission has issued a receipt for the Preliminary Prospectus.

The Preliminary Prospectus has been filed under Multilateral Instrument 11-102 Passport System in British Columbia, Alberta, Saskatchewan, Manitoba, Quebec and Newfoundland and Labrador. A receipt for the Preliminary Prospectus is deemed to be issued by the regulator in each of those jurisdictions, if the conditions of the Instrument have been satisfied.

January 30, 2018

(Signed) “Abel Lazarus”

Abel Lazarus

Director, Corporate Finance

SEDAR Project #2723854